Archives

by in
Entry Author Date Location
Celgene Puts $35M into VentiRx, Gets Option to Buy Cancer Drugmaker 10/03/12 Seattle
Exelixis and Onyx Await Their Cancer-Drug Fates 09/18/12 San Francisco
Alder Gets $3.5M Milestone as Bristol-Myers Starts Crohn’s Study 08/27/12 Seattle
San Diego Life Sciences Roundup: Amylin Buyout, PDUFA, & More 07/05/12 San Diego
Bristol-Myers Buys Amylin for $5.3B, Getting Diabetes Drugs 06/29/12 San Diego
Merck Bets $15M on Ambrx’s “Smart Bomb” Antibodies 06/18/12 San Diego
Bristol-Myers Wrangles Top Academics to Study Immunity in Cancer 06/07/12 New York
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
The 2012 New York ASCO Checklist 05/24/12 New York
Aveo Kidney Cancer Drug Shows Safety Edge in Pivotal Study 05/16/12 Boston
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
NY’s Cancer Research Institute Looks to Boost Cancer Immunotherapy 05/09/12 New York
SD Life Sciences Roundup: Amylin, Illumina, AstraZeneca Acquires Ardea, & More 04/27/12 San Diego
Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs 04/19/12 Seattle
Oncothyreon Marches On With ‘Son of Stimuvax’ Cancer Vaccine 04/10/12 Seattle
Amylin Booms on Report it Rejected Bristol’s $3.5B Takeover Bid 03/28/12 San Diego
Vertex Stays in HepC Game, as All-Oral Combo Passes Small Study 02/23/12 Boston
Enanta Enters HepC Big Leagues, With $34M Upfront From Novartis 02/21/12 Boston
Will New Business Models Enhance or Endanger Drug Discovery? 02/16/12 National
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
A Good News-Bad News Night for Bristol’s Diabetes and Hepatitis Drugs 01/19/12 New York
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
The Top 10 Traffic-Getting Stories at Xconomy San Diego 12/28/11 San Diego
A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine 12/23/11 San Diego
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
The Stroke Prevention War is On: FDA Approves J&J/Bayer Contender 11/07/11 New York
Ariad’s Second Cancer Drug Found Safer Than Expected in Early Review of Key Study 11/07/11 Boston
Roche Acquires Anadys, Wests Create $100M Fund, Johnson & Johnson Makes Room for 20 Startups, & More San Diego Life Sciences News 10/20/11 San Diego
Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors 10/18/11 Seattle
Page 2 of 8 « previous page · next page »